| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Array Analysis | 4 | 2021 | 504 | 1.130 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2018 | 229 | 1.040 |
Why?
|
| Wnt1 Protein | 7 | 2018 | 101 | 0.720 |
Why?
|
| Proteomics | 5 | 2021 | 1422 | 0.630 |
Why?
|
| Mammary Tumor Virus, Mouse | 5 | 2018 | 122 | 0.580 |
Why?
|
| Mammary Glands, Animal | 7 | 2018 | 546 | 0.560 |
Why?
|
| Gene Expression Profiling | 8 | 2016 | 5239 | 0.460 |
Why?
|
| Breast Neoplasms | 17 | 2021 | 16049 | 0.400 |
Why?
|
| Proteins | 2 | 2021 | 1986 | 0.390 |
Why?
|
| Receptor, ErbB-2 | 8 | 2019 | 2616 | 0.380 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2016 | 592 | 0.380 |
Why?
|
| Mice | 46 | 2021 | 35282 | 0.370 |
Why?
|
| Signal Transduction | 17 | 2021 | 12133 | 0.370 |
Why?
|
| Autoantigens | 4 | 2016 | 238 | 0.350 |
Why?
|
| Animals | 47 | 2021 | 60946 | 0.290 |
Why?
|
| Wnt Proteins | 4 | 2021 | 399 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2020 | 9064 | 0.280 |
Why?
|
| Trans-Activators | 4 | 2003 | 1624 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 208 | 0.280 |
Why?
|
| Smad1 Protein | 4 | 2011 | 36 | 0.270 |
Why?
|
| Genes, Dominant | 1 | 2006 | 342 | 0.260 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 717 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 802 | 0.240 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3288 | 0.220 |
Why?
|
| Mice, Transgenic | 11 | 2013 | 4229 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2020 | 464 | 0.220 |
Why?
|
| Cell Line, Tumor | 17 | 2021 | 14850 | 0.220 |
Why?
|
| Receptors, Estrogen | 4 | 2021 | 2122 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 3 | 2016 | 712 | 0.210 |
Why?
|
| Neuroendocrine Tumors | 2 | 2020 | 649 | 0.210 |
Why?
|
| Pyridines | 2 | 2020 | 1289 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 2395 | 0.210 |
Why?
|
| Pyrroles | 2 | 2017 | 594 | 0.210 |
Why?
|
| ErbB Receptors | 3 | 2021 | 2329 | 0.200 |
Why?
|
| Friedreich Ataxia | 1 | 2021 | 40 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 2387 | 0.190 |
Why?
|
| Calcium | 2 | 1999 | 1557 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2018 | 4907 | 0.190 |
Why?
|
| Indoles | 2 | 2017 | 1021 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2020 | 695 | 0.180 |
Why?
|
| Enterocytes | 1 | 2021 | 75 | 0.180 |
Why?
|
| Insulins | 1 | 2020 | 20 | 0.180 |
Why?
|
| Retinoids | 1 | 2021 | 171 | 0.180 |
Why?
|
| Ileum | 1 | 2021 | 168 | 0.180 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 7415 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 164 | 0.180 |
Why?
|
| Protein Kinase C | 2 | 2018 | 397 | 0.180 |
Why?
|
| Cell Proliferation | 9 | 2020 | 7300 | 0.170 |
Why?
|
| Isotretinoin | 1 | 2020 | 158 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 34 | 0.170 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 10623 | 0.170 |
Why?
|
| Quality Control | 1 | 2021 | 461 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2021 | 1689 | 0.170 |
Why?
|
| Female | 38 | 2021 | 147098 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2016 | 5793 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 365 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 1295 | 0.160 |
Why?
|
| Stem Cells | 3 | 2018 | 1243 | 0.160 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 197 | 0.160 |
Why?
|
| Phenylurea Compounds | 2 | 2020 | 598 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 885 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2019 | 5292 | 0.160 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 45 | 0.160 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2018 | 36 | 0.160 |
Why?
|
| Transcriptome | 2 | 2018 | 1951 | 0.160 |
Why?
|
| NIMA-Related Kinases | 1 | 2018 | 11 | 0.160 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2018 | 24 | 0.160 |
Why?
|
| Cytokines | 3 | 2017 | 2867 | 0.160 |
Why?
|
| Receptor, trkA | 1 | 2018 | 39 | 0.160 |
Why?
|
| Prodrugs | 1 | 2020 | 220 | 0.160 |
Why?
|
| Proteome | 2 | 2021 | 577 | 0.160 |
Why?
|
| Tamoxifen | 4 | 2016 | 883 | 0.150 |
Why?
|
| MutL Proteins | 1 | 2017 | 30 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 480 | 0.150 |
Why?
|
| Bone Neoplasms | 3 | 2021 | 2652 | 0.150 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 143 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 5227 | 0.150 |
Why?
|
| Biomarkers | 4 | 2021 | 5172 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 604 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2018 | 115 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 210 | 0.150 |
Why?
|
| Anilides | 1 | 2020 | 287 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 224 | 0.150 |
Why?
|
| Cell Division | 3 | 2013 | 2554 | 0.150 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2017 | 130 | 0.150 |
Why?
|
| Androgen Antagonists | 1 | 2020 | 429 | 0.140 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2015 | 505 | 0.140 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2016 | 8 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 107 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 128 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 627 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 2018 | 153 | 0.140 |
Why?
|
| Ubiquitin | 2 | 2021 | 342 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 131 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 65 | 0.140 |
Why?
|
| Hexosamines | 1 | 2016 | 26 | 0.140 |
Why?
|
| Metformin | 1 | 2020 | 390 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 203 | 0.140 |
Why?
|
| Interleukin-2 | 1 | 2020 | 851 | 0.140 |
Why?
|
| Morpholines | 1 | 2018 | 293 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 588 | 0.130 |
Why?
|
| Aminopyridines | 1 | 2018 | 219 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 636 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 522 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 2018 | 480 | 0.130 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 172 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 446 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 217 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 2520 | 0.130 |
Why?
|
| Cell Cycle | 5 | 2020 | 2115 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2017 | 255 | 0.130 |
Why?
|
| Humans | 42 | 2021 | 270506 | 0.130 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 106 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2016 | 831 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 142 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 622 | 0.130 |
Why?
|
| Neoplasm Transplantation | 4 | 2021 | 1532 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2020 | 2954 | 0.130 |
Why?
|
| Everolimus | 1 | 2017 | 419 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 251 | 0.120 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 137 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 4 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 186 | 0.120 |
Why?
|
| Carcinogenesis | 3 | 2020 | 1048 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2016 | 529 | 0.120 |
Why?
|
| Phosphorylation | 6 | 2019 | 4885 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2016 | 269 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 427 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1293 | 0.110 |
Why?
|
| Casein Kinase Idelta | 1 | 2013 | 6 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 5238 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 1559 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 40 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 2017 | 418 | 0.110 |
Why?
|
| Synapses | 1 | 2017 | 530 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 2 | 2013 | 222 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 469 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 1459 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2018 | 2480 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 382 | 0.110 |
Why?
|
| MCF-7 Cells | 3 | 2021 | 551 | 0.110 |
Why?
|
| Colitis | 1 | 2016 | 338 | 0.110 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 516 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2018 | 1798 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 3930 | 0.110 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 3097 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2980 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 7154 | 0.100 |
Why?
|
| Heterografts | 3 | 2019 | 749 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2016 | 888 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 11816 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 2017 | 1415 | 0.100 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 227 | 0.100 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 1079 | 0.100 |
Why?
|
| Keratin-6 | 1 | 2011 | 39 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 2221 | 0.100 |
Why?
|
| Smad Proteins | 2 | 2002 | 92 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1469 | 0.090 |
Why?
|
| Bone Development | 1 | 2011 | 82 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
| Polyomavirus | 1 | 2010 | 30 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1574 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2016 | 848 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 343 | 0.090 |
Why?
|
| Cell Movement | 4 | 2021 | 2498 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1508 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2020 | 1336 | 0.090 |
Why?
|
| Genes, erbB-2 | 1 | 2010 | 232 | 0.090 |
Why?
|
| Cell Line | 5 | 2016 | 5128 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 770 | 0.080 |
Why?
|
| Estrogens | 2 | 2010 | 758 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 3148 | 0.080 |
Why?
|
| Cornea | 1 | 2014 | 633 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2018 | 1864 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2016 | 1584 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2017 | 1798 | 0.080 |
Why?
|
| Smad8 Protein | 1 | 2008 | 9 | 0.080 |
Why?
|
| Smad5 Protein | 1 | 2008 | 29 | 0.080 |
Why?
|
| Activin Receptors, Type I | 1 | 2008 | 50 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2008 | 75 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 1261 | 0.080 |
Why?
|
| Apoptosis | 6 | 2019 | 7755 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2021 | 4343 | 0.080 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 749 | 0.070 |
Why?
|
| Cell Survival | 3 | 2020 | 3061 | 0.070 |
Why?
|
| Protein Binding | 4 | 2019 | 3480 | 0.070 |
Why?
|
| Male | 16 | 2021 | 127458 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 1569 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 14502 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 1906 | 0.070 |
Why?
|
| DNA Damage | 1 | 2015 | 1987 | 0.070 |
Why?
|
| Mullerian Ducts | 1 | 2008 | 78 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2084 | 0.070 |
Why?
|
| Autophagy | 1 | 2013 | 931 | 0.070 |
Why?
|
| Lung | 1 | 2018 | 3241 | 0.070 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2006 | 42 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2020 | 991 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 110 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 5663 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 684 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2019 | 579 | 0.070 |
Why?
|
| Skin | 3 | 2013 | 1283 | 0.070 |
Why?
|
| Ovariectomy | 3 | 2017 | 336 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1082 | 0.070 |
Why?
|
| Hypertension | 1 | 2015 | 1584 | 0.070 |
Why?
|
| Estradiol | 3 | 2017 | 761 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 902 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 634 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1511 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 4884 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1512 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2018 | 1347 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 2346 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 328 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2005 | 566 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2020 | 350 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 1228 | 0.060 |
Why?
|
| Disease Progression | 3 | 2021 | 6888 | 0.060 |
Why?
|
| COS Cells | 2 | 2000 | 387 | 0.060 |
Why?
|
| Base Sequence | 2 | 2018 | 4929 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 163 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 749 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5444 | 0.050 |
Why?
|
| Quinazolines | 3 | 2015 | 934 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2011 | 898 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 668 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 833 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2020 | 1706 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 4052 | 0.050 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2021 | 34 | 0.050 |
Why?
|
| Prognosis | 5 | 2020 | 22229 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2021 | 35 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 1712 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 50 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 50 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 5936 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 99 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4773 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2020 | 128 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2020 | 31 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2020 | 169 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2020 | 183 | 0.040 |
Why?
|
| Genes | 1 | 2000 | 478 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 154 | 0.040 |
Why?
|
| Lanthanum | 1 | 1999 | 5 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 256 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 46 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 41 | 0.040 |
Why?
|
| Thapsigargin | 1 | 1999 | 41 | 0.040 |
Why?
|
| Nifedipine | 1 | 1999 | 25 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 54 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 435 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 764 | 0.040 |
Why?
|
| Verapamil | 1 | 1999 | 79 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 59 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2021 | 262 | 0.040 |
Why?
|
| Phospholipase C gamma | 1 | 1999 | 58 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2000 | 880 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2021 | 252 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 83 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 1006 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 907 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1999 | 134 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 701 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 135 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 809 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 847 | 0.040 |
Why?
|
| CELF1 Protein | 1 | 2018 | 46 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2021 | 4163 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 7701 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 283 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 1638 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2018 | 6221 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 506 | 0.040 |
Why?
|
| Calmodulin | 1 | 1999 | 248 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2018 | 342 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 271 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 205 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 131 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 44 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 4278 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 656 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 745 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10254 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 4167 | 0.040 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2017 | 79 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 125 | 0.040 |
Why?
|
| Exons | 1 | 2000 | 1351 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 196 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2019 | 718 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1999 | 633 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 6123 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 253 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2017 | 367 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 72 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 1876 | 0.030 |
Why?
|
| Phenotype | 2 | 2019 | 6395 | 0.030 |
Why?
|
| ras Proteins | 1 | 2020 | 783 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1995 | 84 | 0.030 |
Why?
|
| Myelin Basic Protein | 1 | 1995 | 85 | 0.030 |
Why?
|
| Tenascin | 1 | 2015 | 56 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1472 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1096 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2020 | 1162 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2113 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 717 | 0.030 |
Why?
|
| Genes, p53 | 2 | 2013 | 1122 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 353 | 0.030 |
Why?
|
| Transfection | 2 | 2010 | 2988 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 849 | 0.030 |
Why?
|
| Ipilimumab | 1 | 2020 | 749 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 312 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 1698 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 1009 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 1082 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 4067 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 2547 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 1589 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 383 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 253 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 105 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 123 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2014 | 163 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2016 | 745 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2017 | 34185 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 838 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 1411 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 155 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 207 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 628 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 174 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1610 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 323 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 83 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 759 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 2506 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 3105 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 747 | 0.030 |
Why?
|
| Kinetics | 1 | 1995 | 2098 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 2742 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 1658 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 375 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 3254 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 141 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 355 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 89424 | 0.020 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 12 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 250 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 446 | 0.020 |
Why?
|
| Trabecular Meshwork | 1 | 2011 | 12 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2013 | 250 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 1937 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 3593 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2010 | 1848 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6269 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2017 | 1076 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2011 | 39 | 0.020 |
Why?
|
| Survival Rate | 2 | 2020 | 12429 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 462 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 15698 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 217 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1328 | 0.020 |
Why?
|
| Rats | 1 | 2020 | 6204 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 2401 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 208 | 0.020 |
Why?
|
| Oncogenes | 1 | 2013 | 677 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 133 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 5028 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 487 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 1653 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 5509 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 527 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 72809 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 1177 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 707 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 1104 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 518 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1999 | 1896 | 0.020 |
Why?
|
| Mutation | 3 | 2019 | 15579 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 2734 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 30768 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 13880 | 0.020 |
Why?
|
| Progesterone | 1 | 2011 | 528 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 2568 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 3385 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 3362 | 0.020 |
Why?
|
| Genome, Human | 1 | 2016 | 1897 | 0.020 |
Why?
|
| Pregnancy | 2 | 2013 | 7820 | 0.020 |
Why?
|
| Adult | 3 | 2021 | 80609 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1232 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 1429 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2008 | 65 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 5705 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9480 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 2006 | 18 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 638 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2385 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 32280 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 2049 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 9002 | 0.020 |
Why?
|
| Mitogens | 1 | 2005 | 76 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 3983 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 9323 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 3595 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2008 | 306 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 582 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 257 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10092 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2015 | 3603 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 4875 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 5122 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 22103 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 8544 | 0.010 |
Why?
|
| Genes, myc | 1 | 2003 | 360 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 514 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 3620 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 999 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2000 | 336 | 0.010 |
Why?
|
| beta Catenin | 1 | 2003 | 697 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2000 | 94 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 5114 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 93 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 130 | 0.010 |
Why?
|
| Smad4 Protein | 1 | 2000 | 201 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 652 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 1787 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 1079 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 1503 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 13785 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 16760 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 13255 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 18238 | 0.010 |
Why?
|
| Child | 1 | 2011 | 30138 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 16258 | 0.000 |
Why?
|